Last reviewed · How we verify
HTL0016878.HCl Solution 10 mg — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HTL0016878.HCl Solution 10 mg (HTL0016878.HCl Solution 10 mg) — Nxera Pharma UK Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HTL0016878.HCl Solution 10 mg TARGET | HTL0016878.HCl Solution 10 mg | Nxera Pharma UK Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HTL0016878.HCl Solution 10 mg CI watch — RSS
- HTL0016878.HCl Solution 10 mg CI watch — Atom
- HTL0016878.HCl Solution 10 mg CI watch — JSON
- HTL0016878.HCl Solution 10 mg alone — RSS
Cite this brief
Drug Landscape (2026). HTL0016878.HCl Solution 10 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/htl0016878-hcl-solution-10-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab